PREVENTKD (Prevent Risks by Early interVEntion at Nighttime in Type 1 Diabetes for Kidney Disease)
Status:
Terminated
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the early treatment with a blood pressure
medication (an ACE Inhibitor) can prevent or delay the development of kidney disease
(microalbuminuria) in patients with Type 1 diabetes who have normal blood pressure and urine
albumin levels.
Phase:
Phase 3
Details
Lead Sponsor:
Northwestern University
Collaborators:
Juvenile Diabetes Research Foundation National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)